ROBINS HARLAN S

CIK 00017808512 companiesSEATTLE, WA

SEC Profile

Transactions

Companies

Filings

CIK

0001780851

Recent Transactions

50 trades

Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2026-01-06$16.44/sh−10,000→ 1,222,312 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2025-12-04$16.61/sh−10,000→ 1,232,312 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2025-12-03$18.61/sh−27,212→ 1,242,312 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2025-11-10$14.82/sh−10,000→ 1,269,524 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2025-05-01$7.35/sh−68,412→ 1,279,524 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Common Stock
2025-05-01$6.32/sh+68,412→ 1,347,936 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Stock Option (Right to Buy)
2025-05-01−68,412→ 0 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2025-03-24$9.00/sh−1,698→ 1,279,524 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Common Stock
2025-03-24$6.32/sh+1,698→ 1,281,222 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Stock Option (Right to Buy)
2025-03-24−1,698→ 68,412 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2025-03-05$6.98/sh−40,603→ 1,335,577 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2025-03-05$6.99/sh−56,053→ 1,279,524 total
Award
Adaptive Biotechnologies Corp$ADPT
Common Stock
2025-03-04+355,000→ 1,376,180 total
Award
Adaptive Biotechnologies Corp$ADPT
Common Stock
2024-03-04+354,610→ 1,021,180 total
Award
Adaptive Biotechnologies Corp$ADPT
Common Stock
2023-03-06+354,610→ 666,570 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2022-03-07$12.01/sh−4,517→ 311,960 total
Award
Adaptive Biotechnologies Corp$ADPT
Common Stock
2022-03-04+247,117→ 316,477 total
Award
Adaptive Biotechnologies Corp$ADPT
Stock Option (Right to Buy)
2022-03-04+617,792→ 617,792 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Stock Option (Right to Buy)
2021-11-18−300→ 284,800 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2021-11-18$31.36/sh−300→ 69,360 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Common Stock
2021-11-18$6.55/sh+300→ 69,660 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2021-11-17$32.05/sh−3,700→ 69,360 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Common Stock
2021-11-17$6.55/sh+3,700→ 73,060 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Stock Option (Right to Buy)
2021-11-17−3,700→ 285,100 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Common Stock
2021-10-21$6.55/sh+3,700→ 73,060 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2021-10-21$33.73/sh−3,700→ 69,360 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Stock Option (Right to Buy)
2021-10-21−3,700→ 288,800 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2021-10-20$33.71/sh−3,700→ 69,360 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Stock Option (Right to Buy)
2021-10-20−3,700→ 292,500 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Common Stock
2021-10-20$6.55/sh+3,700→ 73,060 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Common Stock
2021-10-19$6.55/sh+3,800→ 73,160 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2021-10-19$33.76/sh−3,500→ 69,360 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2021-10-19$32.91/sh−300→ 72,860 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Stock Option (Right to Buy)
2021-10-19−3,800→ 296,200 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2021-10-08$32.96/sh−3,895→ 69,360 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Stock Option (Right to Buy)
2021-10-08−3,895→ 70,110 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Common Stock
2021-10-08$6.32/sh+3,895→ 73,255 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Stock Option (Right to Buy)
2021-10-07−3,895→ 74,005 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2021-10-07$33.68/sh−3,695→ 69,360 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2021-10-07$32.50/sh−200→ 73,055 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Common Stock
2021-10-07$6.32/sh+3,895→ 73,255 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2021-10-06$32.27/sh−3,895→ 69,360 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Stock Option (Right to Buy)
2021-10-06−3,895→ 77,900 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Common Stock
2021-10-06$6.32/sh+3,895→ 73,255 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2021-09-15$36.52/sh−2,995→ 70,260 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2021-09-15$37.23/sh−900→ 69,360 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Common Stock
2021-09-15$6.32/sh+3,895→ 73,255 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Stock Option (Right to Buy)
2021-09-15−3,895→ 81,795 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Common Stock
2021-09-14$6.32/sh+3,895→ 73,255 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Stock Option (Right to Buy)
2021-09-14−3,895→ 85,690 total

Companies

Recent Filings

Address

C/O ADAPTIVE BIOTECHNOLOGIES CORPORATION 1165 EASTLAKE AVE E

SEATTLE, WA, 98109

View on SEC.gov